New York University, Langone Health — New York, New York

New York University, Langone Health is a clinical research site located in New York, New York, United States 01006.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

New York University, Langone Health has participated in 1 clinical trials.

Therapeutic areas: Prostatic Neoplasms, Castration-Resistant, Androgen-Resistant Prostatic Neoplasms, Castration Resistant Prostatic Neoplasms.

Sponsors: Arcus Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University, Langone Health?

New York University, Langone Health has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University, Langone Health conducted?

New York University, Langone Health has 1 clinical trials on record. Their work covers Prostatic Neoplasms, Castration-Resistant, Androgen-Resistant Prostatic Neoplasms, Castration Resistant Prostatic Neoplasms.

Is New York University, Langone Health accredited by Crixeo Health?

New York University, Langone Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York University, Langone Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.